Probing oral anticoagulation in patients with atrial high rate episodes. Rationale and design of the Non vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH – AFNET 6) trial
Conclusion NOAH – AFNET 6 will provide robust information on the effect of oral anticoagulation in patients with atrial high rate episodes detected by implanted devices. Graphical abstract
Source: American Heart Journal - Category: Cardiology Source Type: research
More News: Arrhythmia | Aspirin | Atrial Fibrillation | Bleeding | Cardiology | Cardiovascular | Education | Heart | Ischemic Stroke | Stroke | Universities & Medical Training | Vitamin K | Vitamins